Search - tctmd.com

Displaying 1 - 19 of 19

Sort: Relevancy | Date

News Daily News

Oral GLP-1s Provide Benefit in HF Patients: SOUL Subanalysis

L.A. McKeown

February 06, 2026

News Daily News

SURPASS-CVOT Published: Large Trial Confirms CVD Efficacy of Tirzepatide

Michael O'Riordan

December 18, 2025

News Daily News

Valve Thrombosis in TTVR Not Uncommon: Meta-analysis

Caitlin E. Cox

June 17, 2025

News Conference News THT 2025

Tirzepatide Helps in HFpEF Across Spectrum of Obesity Severity

Todd Neale

February 12, 2025

News Conference News HFSA 2024

FINEARTS-HF: New Analyses Ask, Who Benefits Most From Finerenone?

Michael O'Riordan

October 02, 2024

News Daily News

LAAO Over Meds in AF? Demographic, Clinical Factors Are at Play

Todd Neale

March 15, 2024

News Daily News

New Expert Consensus Papers Aim to Boost Management, Outcomes in HFpEF

L.A. McKeown

April 19, 2023

News Conference News AHA 2022

In High BP, Chlorthalidone and Hydrochlorothiazide Have Similar Impact on MACE

Todd Neale

November 05, 2022

News Opinion CV Team Dispatch

July 2022 News Roundup

L.A. McKeown

July 01, 2022

News Daily News

New Revascularization Guidelines Plug Radial Access, Staged PCI, and Shorter DAPT

Michael O'Riordan

December 09, 2021

News Conference News TCT 2021

Good Early Outcomes With PCI in Complex Patients Unsuited to Surgery: OPTIMUM

Michael O'Riordan

November 04, 2021

News Opinion CV Team Dispatch

October 2021 News Roundup

L.A. McKeown

October 01, 2021

News Daily News

VERTIS CV: Ertugliflozin Meets Noninferiority Endpoint but Misses Other Marks

Michael O'Riordan

September 24, 2020

News Conference News ESC 2020

Chinese Data Back Anticoagulants to Prevent COVID-19 Thromboembolism

Caitlin E. Cox

September 04, 2020

News Daily News

Heart, Kidneys, Brain, and More: COVID-19’s Wide-ranging Effects

Michael O'Riordan

July 13, 2020

News Conference News ESC 2019

Beta-blockers Safe, Effective for HFrEF Patients With Renal Dysfunction: Meta-analysis

Yael L. Maxwell

September 12, 2019

News Daily News

Benefits of Statins Only Exceed Harms at Higher 10-Year Risk Thresholds, Study Suggests

Michael O'Riordan

December 03, 2018

News Daily News

CKD Patients Undergoing PCI Much Less Likely to Receive Potent P2Y12 Inhibition

Michael O'Riordan

August 04, 2017

News Daily News

Best Anticoagulant in the TAVR Patient With A-fib? Small Study Makes Case for Apixaban

Michael O'Riordan

January 03, 2017

Advertisement

Oral GLP-1s Provide Benefit in HF Patients: SOUL Subanalysis

SURPASS-CVOT Published: Large Trial Confirms CVD Efficacy of Tirzepatide

Valve Thrombosis in TTVR Not Uncommon: Meta-analysis

Tirzepatide Helps in HFpEF Across Spectrum of Obesity Severity

FINEARTS-HF: New Analyses Ask, Who Benefits Most From Finerenone?

LAAO Over Meds in AF? Demographic, Clinical Factors Are at Play

New Expert Consensus Papers Aim to Boost Management, Outcomes in HFpEF

In High BP, Chlorthalidone and Hydrochlorothiazide Have Similar Impact on MACE

July 2022 News Roundup

New Revascularization Guidelines Plug Radial Access, Staged PCI, and Shorter DAPT

Good Early Outcomes With PCI in Complex Patients Unsuited to Surgery: OPTIMUM

October 2021 News Roundup

VERTIS CV: Ertugliflozin Meets Noninferiority Endpoint but Misses Other Marks

Chinese Data Back Anticoagulants to Prevent COVID-19 Thromboembolism

Heart, Kidneys, Brain, and More: COVID-19’s Wide-ranging Effects

Beta-blockers Safe, Effective for HFrEF Patients With Renal Dysfunction: Meta-analysis

Benefits of Statins Only Exceed Harms at Higher 10-Year Risk Thresholds, Study Suggests

CKD Patients Undergoing PCI Much Less Likely to Receive Potent P2Y12 Inhibition

Best Anticoagulant in the TAVR Patient With A-fib? Small Study Makes Case for Apixaban

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content